Subsequently, we studied the effect of KBP-336, a DACRA with potent activity on calcitonin and amylin receptors, on a rat model of OA with obesity, and we shed light on the unique ability of DACRAs to provide symptom relief along with weight loss. This evidence concerns the gene CALCA and obesity disorder.